The spirochete Borrelia burgdorferi is the causative agent of Lyme borreliosis (Lyme disease) and is transmitted to mammalian hosts by tick vectors. In humans, the bacteria induce a complex disease, which involves the skin, joints, heart, and nervous system. However, the pathogenic principles of this multisystem illness are far from being understood. To disseminate from the site of the tick bite and invade multiple organ sites, spirochetes have to penetrate normal tissue barriers, such as vascular basement membranes and other organized extracellular matrices. Substantial evidence from other invasive bacterial infections suggest that spirochetes may use endogenous or host-derived enzymes-in particular, proteinases-for this purpose. Here we show that B. burgdorferi binds human plasmin(ogen) -mainly via its outer cell surface lipoprotein A. Binding of plasminogen to spirochetal receptor leads to an accelerated formation of active plasmin in the presence of host-derived plasminogen activator. The cellsurface-associated plasmin cannot be regulated by the serum inhibitor ac2-antiplasmin and degrades high-molecular-weight glycoproteins, such as fibronectin. It is suggested that the acquisition of host-derived proteinase plasmin(ogen) contributes to the pathogenicity of B. burgdorferi.
In humans, the spirochete Borrelia burgdorferi induces a multisystem disorder (Lyme borreliosis), which includes skin manifestations, such as erythema chronicum migrans, and acrodermatitis chronica atrophicans, as well as arthritis, carditis, and meningoencephalitis (1) . Little is known about the mechanisms underlying spirochetal invasion. However, microorganisms have been recovered from skin lesions, blood, and cerebrospinal fluid and have been seen in small numbers in tissue sections of myocardium, retina, muscle, bone, spleen, liver, meninges, and brain (1, 2) . Studies on B. burgdorferi infection in animal models-in particular, in micedemonstrate that viable spirochetes are required for induction of the disease (3). Furthermore, spirochetes have been reported to adhere to and penetrate through endothelial cell layers in vitro (4, 5) . These data indicate that B. burgdorferi organisms play an active role in the development of organ pathology. It is therefore of interest to examine features of the spirochetes that may be responsible for their potential to cross tissue barriers and to colonize distant organ sites.
A prerequisite for bacteria to invade normal tissues is the degradation of matrix proteins. There is ample evidence that plasmin, a trypsin-like serine proteinase, is involved in this process (6, 7) . In situ, plasmin is generated by limited proteolysis from its serum-derived zymogen precursor plasminogen by the urokinase-type plasminogen activator (uPA) or tissue-type plasminogen activator (tPA) (8, 9) . The latter enzymes (uPA, tPA) are produced and secreted by a variety of eukaryotic cells-including endothelial cells, in particular-under conditions of inflammation (10, 11) . The activation of plasminogen by uPA and tPA is favored by the attachment of the individual reactants to appropriate highmolecular matrices, including bacterial cell surfaces (12, 13) . Active plasmin has a broad substrate specificity and is able to dissolve blood clots, to degrade constituents of extracellular matrices and basement membranes such as fibronectin, and to activate latent collagenases (14) . Thus plasmin seems to play a role in pericellular proteolysis of both eukaryotic (11) and prokaryotic (6, 7, 15) cells.
A number of bacteria, like Yersinia pestis, produce plasminogen activators that activate host-derived plasminogen (16) . Alternatively, bacteria such as Escherichia coli, group A, C, and G streptococci, and Neisseria gonorrhoeae express surface receptors for plasmin(ogen), which bind plasminogen and facilitate its activation by host-derived plasminogen activators (6, 7, (17) (18) (19) . We have asked whether the spirochete B. burgdorferi uses one of these two pathways.
MATERIALS AND METHODS Materials. We used the plasmin-specific substrate D-valyl-L-leucyl-L-lysylparanitroanilide dihydrochloride (S-2251) and plasminogen (21.7 units/mg) (Chromogenix, Molndal, Sweden); high-molecular-mass (54-kDa) uPA (Ukidan; Serono Laboratories, Freiburg, Germany); two-chain tPA (Paesel and Lorei, Frankfurt); and a2-antiplasmin, tranexamic acid, and aprotinin (Sigma).
Bacteria and Recombinant Outer Surface Protein A (OspA). If not otherwise indicated, the pathogenic B. burgdorferi strain ZS7, grown in BSK medium, was used (3). Moreover, the following strains were used: Z37, NE58, NE11H, NE4 (L. Gem, Neuchatel, Switzerland), ZQ1 (3), and GeHo (20) . Bacteria were washed three times in phosphate-buffered saline (PBS); if required, the second washing step was done with PBS/50 mM tranexamic acid to remove bound plasmin-(ogen). Recombinant OspA was prepared as described (21) .
Immunocytological Staining of Intact Bacteria. Bacteria (3 x 106) in 3 ul of PBS were coated onto microscopic glass slides by air-drying, blocked with PBS/2% bovine serum albumin (BSA) (15 min), and incubated for 1 hr at room temperature with human serum (serum/PBS, 1:2). After being washed three times in PBS/2% BSA the spirochetes were incubated for 1 hr at room temperature with polyclonal goat anti-human plasminogen IgG (no. 3104808; Behringwerke) and then incubated with fluorescein-labeled swine anti-goat IgG antibody (1:20, 30 (24) , isoelectric focusing (Pharmacia ampholytes: 1.45% pH 3.5-10; 0.1% pH 2.5-4.0; 0.2% pH 4-6; 0.2% pH 9-11) and SDS/PAGE under reducing conditions were combined.
Radioactive Ligand Binding. Immobilon-P membranes were blocked (2 hr; PBS/2% BSA) and incubated for 1.5 hr with 125I-labeled plasminogen (iodinated by the chloramine T method) at a concentration of 1.65 nM (1 x 105 cpm/ml) in PBS/2% BSA. The membranes were washed (five times in PBS/2% BSA) and analyzed,by autoradiography.
Scatchard Analysis. Five hundred nanograms of recombinant OspA per well was coated onto microtiter plates (Maxisorb F16, Nunc) overnight. After being washed with PBS (0.05% Tween 20, vol/vol) the plates were blocked with PBS/2% BSA for 2 hr. Coated wells were then incubated with increased concentrations (78 pmol/ml-10 nmol/ml) of a mixture of 12.8% 125I-labeled plasminogen and 87.2% nonlabeled plasminogen in PBS/2% BSA for 1.5 hr at room temperature. After washing (four times in PBS/2% BSA) the bound radioactivity was solubilized by adding 1 M NaOH and then determined. Binding to 5 pg of BSA per ml instead of OspA was taken as control (unspecific binding) and subtracted. For estimation of the Kd the data were transformed according to Scatchard (25) ; the slope of the resultant curve represents -1/Kd.
RESULTS AND DISCUSSION
To test whether B. burgdorferi binds and or activates plasminogen viable spirochetes were incubated in human serum and subsequently analyzed for cell-surface-bound plasminogen with monoclonal or polyclonal antibodies to plasmin-(ogen) (26) . Only bacteria preincubated with serum ( Fig. 1 A-D), but not with PBS ( Fig. 1 E-H), were stained with the antiplasmin(ogen) Igg. The assumption that plasminogen specifically adheres to the surface of B. burgdorferi organisms was further substantiated by the finding that spirochetes also bind purified fluorochrome-labeled plasminogen (Fig. 11) . The fact that this binding is inhibitable in the presence of the lysine analogue tranexamic acid (Fig. 1J) indicates that plasminogen interacts with the surface of B. burgdorferi via its lysine-binding sites (27) .
To determine whether binding of plasminogen to the spirochete facilitates its activation by human plasminogen activators, B. burgdorferi organisms were incubated with plasminogen and either uPA or tPA ( Table 1 ). The proteolytic activity of plasmin was determined with the specific chromogenic substrate S-2251. Activation ofplasminogen by both uPA and tPA ( Data are presented as absorbance change rate per min x 10-3. For spirochetesplasmin, whole spirochetes (4 x 107) were incubated with plasmin (2 x 10-2 units/ml) in the presence or absence of 50 mM tranexamic acid for 1.5 hr at 37°C. Afterward spirochetes were washed, and enzyme activity of cell-bound plasmin was determined with S-2251. Absorbance at 405 nm was monitored for 4 hr, and data were prepared as absorbance change rate per min x 10-3. Spirochetes bind plasmin, and the binding is inhibited by tranexamic acid. Cell-surface-bound enzyme activity is inhibited by the low-molecular-mass plasmin inhibitor aprotinin (1000 units/ml). The results described so far show that B. burgdorferi organisms can bind both human plasminogen and plasmin. We next determined whether the cell-surface-bound plasmin is protected from physiological inhibition. For this purpose, spirochetes were incubated in human serum, which contains high amounts of plasmin inhibitors-in particular, a2-antiplasmin, the main inhibitor of plasmin (29)-in the presence of exogenous tPA. As shown in Fig. 2A considerable plasmin activity was generated under these conditions; the enzyme was inhibited by the low-molecular-weight plasmininhibitor aprotinin. These data indicate that the spirochetebound plasmin exerts its enzymatic activity even in the presence of abundant a2-antiplasmin. This assumption is further substantiated by experiments in which the enzymatic activity ofequivalent amounts ofspirochete-bound or free plasmin was tested after incubation with increased concentrations of a2-antiplasmin (Fig. 2B) . At a concentration of 1 mg of a2-antiplasmin per ml, >70% of the plasmin activity was seen in the presence of bacteria, but only 4% or less was seen in the absence of bacteria. These data strongly suggest that spirochetes protect cell-surface-attached plasmin from binding to a2-antiplasmin. This conclusion is corroborated by the finding that complex formation between a2-antiplasmin and plasmin only occurred when plasmin was added in solution but was not spirochete-associated. This result was shown by incubating spirochetes with an excess of '25I-labeled plasminogen and adding uPA in concentrations allowing processing of both bound and free zymogen into 125I-labeled plasmin. Subsequently, a2-antiplasmin was added, and after centrifugation spirochete-attached and soluble compounds were separated by SDS/PAGE and analyzed by autoradiography (Fig. 2B  Inset) . Complexes between plasmin/a2-antiplasmin of molecular mass 460 kDa were only detected in the soluble fraction (Fig. 2B, lane b) , but were not detected in the spirocheteassociated fraction, which mainly contains noncomplexed plasmin (-90 kDa; Fig. 2B, lane a) (Fig. 3, lane a) . No or only partial degradation of fibronectin was seen when spirochetes were preincubated (i) in the absence of plasmin (Fig. 3, lane b) , (ii) with plasmin in the presence oftranexamic acid (Fig. 3, lane c) , or (iii) with plasmin in the presence of aprotinin (Fig. 3, lane d) .
Although plasmin(ogen) receptors have been isolated from bacteria in the past (6) , corresponding structures from spirochetes have not been identified so far. To elucidate the putative plasminogen-binding structure(s) of B. burgdorferi bacterial lysates from strains corresponding to the genotypes B. burgdorferi sensu strictu and B. burgdorferi garinii (30) were subjected to SDS/PAGE. After their transfer to Immobilon-P membranes (ligand-blotting), the separated proteins (Fig. 4A, silver stain) were incubated with 125I-labeled plasminogen. For all B. burgdorferi strains tested, the autoradiograms (developed after 42 hr) revealed one major binding Complex formation between plasmin is seen only with free plasmin (in supernatants) and is not seen with spirochete-associated enzyme. The molecular mass of plasmin is -90 kDa (kD) and that of the plasmin/a2-antiplasmin complex is "160 kDa.
structure(s) in the molecular mass range of "31 kDa (Fig.  4C ). Upon longer exposure (100 hr), two-five additional bands with molecular masses of '21 kDa, =34 kDa, -55 kDa, and z80 kDa were seen (Fig. 4D) . Concomitant analyses of the gel with an anti-OspA immune serum (Fig. 4B) (A) . Alternatively, the separated proteins were electroblotted onto immobilon-P membranes and analyzed by immuno-(B) and ligand-(C) blotting. OspA of the genotype B. burgdorferi sensu strictu (lanes a, b, e, and g) and genotype B. burgdorferi garinii (lanes c, d, and f) (30) in the expected molecular mass range of -31 kDa (kD) was visualized by immunoblotting with an immune serum against purified recombinant OspA of B. burgdorferi strain ZS7 (B). Immobilon-P membranes were incubated with 125I-labeled plasminogen. Upon short-term exposure (42 hr) one major binding protein was seen in the range of -31 kDa (C). Upon prolonged exposure of the blot (100 hr) additional weaker bands of -21, -34, -55, "60, and "80 kDa were seen (D). Cell lysates of spirochete (strain ZS7) were also separated by two-dimensional gel electrophoresis (31) and analyzed by immunoblotting using a mixture of the anti-OspA mAb LA 31.1 and LA 2.2 (32) (E) or by ligandblotting using 125I-labeled plasminogen (F) as described above. inhibited by tranexamic acid (Fig. 5, lanes d and f. These results clearly show that OspA of B. burgdorferi is a prominent receptor for plasmin(ogen) and that the interaction is mediated by the lysine-binding site of the zymogen. However the data also indicate that B. burgdorferi expresses additional receptors for plasmin(ogen).
Radiolabeled plasminogen binds to immobilized recombinant OspA in a dose-dependent manner (Fig. 6) . The calculated Kd of 0.26 mM estimated from the nonlinear Scatchard blot (data not shown) is in the range of eukaryotic plasminogen receptors (13) . Because Scatchard analysis is applicable only to free solution systems, it is unclear whether this Kd value is accurate and whether there is an additional plasmin(ogen)-binding site with lower affinity on OspA.
Our results show that OspA is a major cell-surface receptor of B. burgdorferi for human plasmin(ogen). The protection of cell-surface-associated plasmin from physiological inhibitors may allow spirochetes to traverse normal tissue barriers, to colonize distant organs, and to propagate pathophysiological processes within affected tissues. This assumption is supported by the finding that spirochete-associated plasmin degrades the extracellular matrix protein fibronectin. Furthermore, the cell-surface-attached proteolytic activity may also protect spirochetes against serum-derived nonspecific or specific antimicrobial compounds, such as complement or specific antibodies. The present findings may have broad (21, 33) . Recombinant OspA was immobilized to microtiter plates and incubated with increased concentrations of 1251-labeled plasminogen (abscissa). After being washed, the OspA/plasminogen complex was solubilized with 1M NaOH. Radioactivity of the solubilized material was determined in triplicates; the amount of bound plasminogen was calculated (ordinate).
implications for invasive bacterial infections and support the concept of association of bacterial invasiveness with the generation of plasmin. Together with previous reports on the expression of endogenous plasminogen activators on Grampositive and Gram-negative bacteria, these data suggest that prokaryotes have evolved at least two independent mechanisms to enhance their pathogenicity by use of the plasminogen-activator system.
